ADENOSINE A3 RECEPTOR MODULATORS

Details for Australian Patent Application No. 2002305386 (hide)

International Classifications

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 10/134,219 26.04.02 US

15 January 2004 Application Open to Public Inspection

Published as AU-A-2002305386

5 February 2004 Amendment Made

The nature of the amendment is: Amend the name of the applicant/patentee to King Pharmaceuticals Research & Development, Inc.

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

3 September 2009 Corrigenda

Applications OPI - Name Index Under the name King Pharmaceuticals Research & Development Inc., Application No. 2002305386, under INID (43) correct the Publication Date to read 24 November 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.